We thank Ramos et al. for their interest in our recent study on sex differences in admission perfusion imaging and ischemic core growth in the DEFUSE 3 cohort. We agree that differences in neuroimaging characteristics between men and women are complex and to accurately characterize the role of sex, many confounding factors can be incorporated to inform on implications for treatment and imaging selection for clinical trials. It is with this understanding that we chose the highly-selected DEFUSE 3 cohort which is a uniform sample of patients with large vessel occlusion (LVO). Of patients screened for DEFUSE 3 but not randomized due to large core or no mismatch, the proportion of women was 21/45 (47%) with large core; and women 5/8 (63%) with mismatch ratio <1.8 and/or mismatch volume <15 mL. The results of our study showed that sex differences exist in baseline imaging characteristics, process measures, clinical outcomes, and imaging outcomes within the DEFUSE 3 group of patients with an LVO, favorable imaging profile, functional independence prior to stroke, and presentation between 6–16 hours from last known well.
We agree that including stroke etiology in the adjusted analysis could alter the effect size of the difference of collateral status between women and men, possibly improving robustness, interpretability and generalizability. Evaluation of the TOAST etiology by sex of the DEFUSE 3 cohort did not result in significant sex differences (p = 0.303 for overall comparison and p = 0.112 for specific to sex difference between large artery atherosclerosis and cardioembolic source). Despite higher incidence of LAA in men and subsequent higher collateral grade found in this group, there is no report of collateral grade by sex in Guglielmi’s analysis of the MR-CLEAN registry.1 However, Berkhemer did indicate that women demonstrated a higher collateral grade within the MR CLEAN patient cohort2, p = 0.031. We acknowledge that the literature is inconsistent in regards to sex differences in collateral status. In the noted analysis of a large unselected patient group presented by Nannoni,3 as with many sub-analyses of sex differences, results are difficult to interpret without knowledge of cohort demographics by sex, i.e. age distribution (females tend to be older), NIHSS (females tend to present with more severe strokes), onset to CT time (females tend to present later) as in supplementary data, these variables seem to correlate with collateral grade.3
Future challenges include studies designed and powered to assess the influence of sex. Large observational studies considering sex-specific confounders would lead to greater generalizability of clinical trials. Incorporation of female-specific risk factors as well as incorporation of larger proportions of patients >75 years old is imperative. By presenting sex differences in a highly selected group of slow-progressing LVOs, this article is a necessary step towards understanding of the role of sex on ischemic stroke evolution.
Footnotes
CONFLICTS/DISCLOSURES
Dula - Lone Star Stroke Research Consortium
Mlynash – none
Albers –NIH, equity in iSchemaView and consulting for Genentech, Medtronic and iSchemaView
Warach –NINDS StrokeNet, consulting for Genentech, Lone Star Stroke, State of Texas during the conduct of the study; and personal fees from Abbvie Pharmaceutical
REFERENCES
- 1.Guglielmi V, LeCouffe NE, Zinkstok SM, Compagne KCJ, Eker R, Treurniet KM, et al. Collateral circulation and outcome in atherosclerotic versus cardioembolic cerebral large vessel occlusion. Stroke. 2019;50:3360–3368 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Berkhemer OA, Jansen IG, Beumer D, Fransen PS, van den Berg LA, Yoo AJ, et al. Collateral status on baseline computed tomographic angiography and intra-arterial treatment effect in patients with proximal anterior circulation stroke. Stroke. 2016;47:768–776 [DOI] [PubMed] [Google Scholar]
- 3.Nannoni S, Sirimarco G, Cereda CW, Lambrou D, Strambo D, Eskandari A, et al. Determining factors of better leptomeningeal collaterals: A study of 857 consecutive acute ischemic stroke patients. J Neurol. 2019;266:582–588 [DOI] [PubMed] [Google Scholar]
